Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs
The effectiveness of antiarrhythmic drugs in the elderly is similar to that in younger patients. However data for «the very elderly» are lacking. Elderly patients are more vulnerable to adverse drug reactions (ADRs) because of age-related changes of pharmacokinetics, co-morbidity and drug interactio...
Main Authors: | E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1343 |
Similar Items
-
Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs
by: E. A. Ushkalova, et al.
Published: (2016-09-01) -
Antiarrhythmic Drug Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy
by: Sean P. Gaine, et al.
Published: (2023-04-01) -
Antiarrhythmic Drug Dosing in Children—Review of the Literature
by: Nathalie Oeffl, et al.
Published: (2023-05-01) -
Effects of Antiarrhythmic Drugs on Antiepileptic Drug Action—A Critical Review of Experimental Findings
by: Kinga K. Borowicz-Reutt
Published: (2022-03-01) -
Assessment of the risk of polymorphic ventricular tachycardia development in patients with drug-induced QT interval prolongation caused by class III antiarrhythmic drugs
by: V.A. Snezhitskiy, et al.
Published: (2022-06-01)